In developing a Reference Material foralkaline phosphatase, we studied the stability, kinetic properties, and commutability of separate preparations of the purified enzyme from human liver, intestine, bone, and placenta. The Michaelis constants (Km) for the preparations from liver, bone, and intestine agreed well with the Km values we obtained for five human serum specimens, whereas that for the placental isoenzyme differed significantly. The first three isoenzymes exhibited nearly identical response-surface patterns, which closely paralleled those observed for 12 human serum specimens (commutability), but not that of the placental isoenzyme.
nearly identical response-surface patterns, which closely paralleled those observed for 12 human serum specimens (commutability), but not that of the placental isoenzyme.
Thus, we believe that a reference material could equally well consist of either the bone, intestinal, or liver isoenzyme. All four isoenzymes were satisfactorily stable in temperatureaccelerated degradation studies. We chose the liver isoenzymeas an appropriate reference material because liver tissue is easier to obtain than bone or intestine and the isoenzyme is abundant in liver, is easy to extract, and is the one most commonly increased in human serum. This material is stable at -20 "C, is free of interfering and degradative enzymes and, being of human origin, is commutable with the enzyme in human serum.
Additional Keyphreses: isoenzymes -response-surface patterns -multivariate optimization studies
The purpose of this study was to develop a Reference
Material
(BVTM)
for alkaline phosphatase (ALP).2 We studied the properties of purified preparations ofthe three isoenzymes that normally are present in human serum (apparently originating from liver, bone, and intestine) (1), and human placental isoenzyme. We included the placental isoenzyme because of the relatively easy availability of human placental tissue and because this isoenzyme is widely used in commercial control materials. We deter- In the isoenzyme purifications, ALP activity was mea- Isoenzyme preparations. ALP was purified from human liver, smallintestine, and bone.All tissues were obtained at autopsy, were negative forhepatitis B surface antigen,and were stored immediately at -70 #{176}C until processed. Samples were homogenized and centrifuged at 4#{176}C and chromatographed at 25 "C.The initial preparation ofeach tissue was different but subsequent extraction and purification steps were similar.
Preparation and purification procedures were as follows: #{149} Liver, 500 g, was cut into1-cm cubes, trimmed to remove fat, washed with physiological saline, and extracted and purified as described by Trepanier et al. (7) . #{149} Bone, 50 g of vertebrae, was cut into1-cm pieces with an autopsy saw. The pieces were extracted with buffer and butanol. Subsequent purification forthe aqueous phase is described below. Ten grams ofribwas processed similarly.
#{149}
Intestinal mucosal cellswere scraped from 200 g of washed smallintestine. The scrapings were homogenized (7) with Tris buffer, treated with n-butanolat 0#{176}C, and centrifuged;the supernatant fluid was processed as described below.
After initial preparation and extraction of the tissues, the isoenzymes were purified by precipitation with acetone, affinity chromatography on concanavalin A-Sepharose, and anion-exchange chromatography on DEAE-Sephadex
(7).
Human placental ALP (Calbiochem) was further purified by anion-exchange chromatography on DEAE-Sephadex (7) . The purification scheme is given in Table 1 .
Preparation of isoenzyme pools. We prepared a pooled specimen ofeach ALP isoenzyme (liver, bone,intestine, and placenta) by adding the purified isoenzyme to a matrix (7) containing, 
quota of de-ionized, degassed water).
Half ofeach pool was kept in its liquid form and the other half was lyophilized. The pools were stored at -20 "C.
Stability
of pools. Temperature-accelerated degradation tests (10) were conducted forboth the liquid and lyophilized pools for each isoenzyme. Some of each pool was kept at 4, 37, and 56#{176}C, and specimens were taken at predeterminedi intervals during six months. To minimize analytical variability, we dated these specimens when they were removed from each' temperature, and storedthem at -20 #{176}C untilall were collected. We then measured ALP activity by assaying all specimens for one isoenzyme from a singlestorage 
Results

Purification of isoenzymes
Disc gel electrophoresis showed only one band of activity for each of the isoenzymes, except for the intestinal isoenzyme, which showed two activity bands (one major and one minor). The activity bands for each of the isoenzymes had about the same electrophoretic mobility. The intestine and bone preparations contained only one band staining for protein, but the liver and placental preparations showed multiple bands. For the bone isoenzyme, however, the protein band did not exhibit the same R1 value as the activityband.
Electrophoresis of the isoenzyme pools on agarose gel final pooled materials. Individual activities of amylase, creatine kinase, aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase in the enzyme poois were 2 U/L orless at ALP activities of 47, 174, 70, and 313 UIL for bone, liver, intestinal, and placental isoenzymes, respectively.
Stability of lsoenzyme Pools Figure 1 shows the curves for temperature-accelerated degradation (decay) of the liverisoenzyme pool; the other isoenzymes exhibited similar curves. These data were used to predict the relative stability ofeach isoensyme pool, and all indicated satisfactory stabilities for all four isoenzymes ( Table 3 ). The liver and placental isoenzyme pools appeared to be the most stable.
Temperature-dependent renaturation
of ALP activity in frozen liquid and lyophilized serum pools is well documented (18,19 ). An increase of about 1 U/h at 25 #{176}C was observed at the 200 UIL activity level. To restore the original activity of the ALP materials, we routinely incubated the materials in a waterbath at 25 "C for 24 h before use. Materials so treated were only used for 4 h (half of one working day). Table 4 lists theKm and Vm valueswe found forthe four ALP isoenzymes and five human serum samples. The Km values for the bone, intestinal, and liver isoenzymes were very similar but that for the placental isoenzyme was less. The five serum specimens were from a nine-year-old child, a normal adult, and patients with hepatitis B, cirrhosis, or cardiac arrest; theirKm values agreed closely with those for the liver, bone,and intestinal isoenzymes.
Michaelis Constants
In most of the previous determinations of Km forhuman ALP isoenzyme, pNPP was not the substrate (17) . Eaton and Moss (20), however, who did use pNPP as substrate, reported values of 0.8, 0.6, and 0.7 mmol/L for liver, bone, and intestinal isoenzymes, respectively-results very similarto ours.
Multivariate Response-Surface Studies
The fourpurified ALP isoenzymes exhibited very similar response-surface patterns for various reaction conditions, as shown in the predicted activity plots in Figures 2 through 4 . We obtained these data by varying one factor and holding the other two factors constant at the central experimental coordinate (Table 2 ). The responses of the purified liver, 
Discussion
55
The quality of enzyme activity measurements could be greatly improved if enzyme reference materials were available that responded the same as endogenous serum enzymes to various assay conditions. Bowers et al. (21) documented the differences among some animal sources ofALP, ALP in commercial controls, and endogenous human serum ALP. (5) alcoholic hepatitis patient; (6) nine-year-oldboy;(7) hepatitis B patient; (8) bone, and intestinal isoenzymes closely parallel the response observed for serum specimens from a normal adult, two children, and patients with various diseases thatwould be expected toalterthepatterns forserum ALP isoenzymes.
____________________
with these proposed criteria for specific activity. First, highly purified enzyme preparations do not usually exhibit the stability required for enzyme reference materials and require the addition of a stabilizer (i.e., albumin). Second, human tissues are not readily available for enzyme purification, and the yields associated with obtaining ultrapure enzymes are relatively poor. Therefore, we believe that ultrapurity should not be a mandatory criterion for enzymes used in Reference Material preparation. Rather, we propose that enzyme materials that have been purified by some combination of classical techniques (i.e., ammonium sulfate precipitation, affinity chromatography, gel ifitration, ionexchange chromatography) and are free of interfering and degradative enzymes are appropriate for Reference Materials. This proposal is supported by the fact that preparation of Reference Materials involves dilution of the purified enzymes insome matrix that simulates patients' specimens. The specific activities we obtained for our purified isoenzymes are in some casesfar from the highest reported, but they compare well with reported values for preparations purified by procedures similar to the ones we used. The differences between our results and previously reported results for specific activities and purification factors are probablyattributable to differences in the purification procedure and the method used to measure activity. Because the purified isoenzymes were to be added to a matrix simulating humai specimens, our goal was not to obtain ultrapure isoenzyne preparations, but rather to obtain ALP isoenzyme preparations of reasonable purity that were not contaminated with other ALP isoenzymes and interfering or degradative enzymes.
Because the liver, bone, and intestinal ALP isoenzymes behave almost identically, we believe that a Reference
Material for ALP could reasonably consist of any one of these isoenzymes. We propose that the purified liver isoenzyme pool (liquid or lyophilized) we described is an appropriate Reference Material (BVTM) for ALP: (a) this material is stable; (b) it is commutable with human serum ALP; (c) it is free from interfering and degradative enzymes; (d) its kinetic properties closely resemble those of the bone and intestinal isoenzymes and endogenous human serum ALP;
and (e) it is of human origin. Additionally, the matrix of this material simulates that of human specimens and contains the necessary activators. The liver isoenzyme was chosen over the bone and intestinal isoenzymes because liver tissue is easier to obtain, the isoenzyme is abundant in the liver, ALP is much easier to extract from liver tissue than it is from bone or intestine, and the liver isoenzyme is the one most commonly increased in serum.
These materials were supplied to the AACC Alkaline Phosphatase Study Group for use in interlaboratory verification of their recommended method for determination of ALP.
Appendix.
Equation + bj2xy + b13xz + b2yr where b0 = intercept b1,b2,b3= first-order main-effect coefficients b11, b, b = second-order main-effect coefficients b12,b13,b = first-order interaction coefficients x, y, z = pH, 2A2M1P concentration, and pNPP concentration, respectively.
